Oncology trials present a unique challenge in the clinical research space, particularly when it comes to patient recruitment. The identification windows are narrow, yet participation in precision trials can have life saving options for many patients with an unfortunate diagnosis. The CEO and Co-Founder of Deep Lens, Dave Billiter talks with us about how this recruitment is such a challenge and what tools may be available to help this process as well as how communication is key to running a successful recruitment campaign.